Biased Agonism: An Emerging Paradigm in GPCR Drug Discovery

Bioorganic and Medicinal Chemistry Letters - United Kingdom
doi 10.1016/j.bmcl.2015.12.024
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Biased Agonism in Drug Discovery - Is It Too Soon to Choose a Path?

Molecular Pharmacology
Molecular MedicinePharmacology
2018English

Biased Receptor Signaling in Drug Discovery

Pharmacological Reviews
Molecular MedicinePharmacology
2019English

Lead the Way in GPCR Drug Discovery

Chemical and Engineering News
Chemical Engineering
2005English

Zebrafish an Emerging Model for Preclinical Drug Discovery

International Journal of Research in Pharmaceutical Sciences
ToxicologyPharmaceuticsPharmacology
2020English

A Pharmacological Primer of Biased Agonism

Endocrine, Metabolic and Immune Disorders - Drug Targets
EndocrinologyAllergyImmunologyMetabolismDiabetes
2011English

Chemogenomics: An Emerging Strategy for Rapid Target and Drug Discovery

Nature Reviews Genetics
GeneticsMolecular Biology
2004English

Small Molecule PROTACs: An Emerging Technology for Targeted Therapy in Drug Discovery

RSC Advances
ChemistryChemical Engineering
2019English

Emerging Role of Electron Microscopy in Drug Discovery

Trends in Biochemical Sciences
BiochemistryMolecular Biology
2019English

A New Era for GPCR Research: Structures, Biology and Drug Discovery

Acta Pharmacologica Sinica
MedicinePharmacology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy